Chronic Diseases Value, Affordability, and… Understanding the Full Value of Long-Acting Therapies: less is more? Read more
Health Technology Assessment… Value, Affordability, and… An Analysis of NICE’s Optimised Decisions from 2015 to 2024 Read more
Health Technology Assessment… Value, Affordability, and… Broader value and societal… The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region Read more
Cell and Gene Therapies Value, Affordability, and… Budget Impact Analysis Challenges and Solutions for Budget Impact Analysis of Gene Therapies Read more
Drug Development/R&D Economics of Innovation Competition The Importance of Diversity of Supply in Rare Diseases Markets Read more © VK Studio at stock.adobe.com
Back Bulletin October 2022 The power of communication is health economics Read more Bulletin September 2022 An alphabet of priorities for the new Health Secretary Read more Bulletin August 2022 Balancing access, innovation and sustainability Read more Bulletin July 2022 Special Edition: OHE Masterclass Series Read more